Essay on International Legislation on Genetically Modified Babies

An embryo genetically modified in a specific way with a purpose of along with specific traits for producing a child. There are different cases in such a scenario in which many of the times favorable traits added and unfavorable traits have been removed and vice versa. It’s almost straightly out of the fiction of sciences, and it seems like this also, such children are termed as designer children in medical history and they are a reality now a day. The process is little complicated and sensitive and it is yet the curiosity that how this process works actually. These kids are the result of successful IVF technology in medical history and which is increasing its future as well. It is almost related to natural next step that with the help of embryo a GMO baby is produced with an embryo as this method was discovered by a scientist in the laboratory while experimenting this research of producing genetically modified babies. (Araki & Ishii, 2014)

To choose personality and ethics traits, and not just optimizing genes for the prevention of diseases, is not the only potential for them to do this research successfully. A number of latest technologies have been involved now to produce a complete GMO baby in which Preimplantation Genetic Diagnosis (PGD) is a technique that involves implementation of deviation of the embryo to certain genetic disorders and genetic defects are identified through preimplantation. This terminology is known as CRISPR-CAS9, as this is a new evolution in genetic technology. In this method, babies are produced by DNA Fragments modification that correct and prevents diseases in the body that causes genetic errors that refrain from being giving birth to baby genes. From a DNA molecule, a certain type of genes can be removed or added with this CAS9 special technology, and gene edited embryos fertilization has been used recently with this.

 "For the sake of all humankind, genome editing is unquestionably recorded under the most promising science undertakings, and gene therapy in the history of medicine becomes a watershed”. The experts argued this in a report called “Updating its Reflection on the Human Genome and Human Rights” that was published in a meeting held in UNESCO under experts of International Bioethics Committee (IBC). There are some cautions mentioned in that report that “Serious concerns are raising by this development and it requires some particulars precautions as well, on germline human genome editing should be applied and new modifications on hereditary should be introduced, and hence future generations can be transmitted this properly”. (Soini, 2012)

Testing of genetic screening and inherited diseases have been introduced now with the advancement in medical sciences technology, the possibility of genetic editing and cloning, the use of embryonic stem cells in medical research and gene therapy, is now very much advanced in both non-medical and medical ends. IBC says that for prevention, diagnostic or any therapeutic reasons on the human genome interventions should be admitted, the equal dignity of renewing eugenics and human beings and the inherent "jeopardize" an alternative would be a good thing to argue.

 Researches findings suggests that producing genetically modified babies is not a good experiment as this not only making the science very advanced but this thing is making another issue in the human body as a very hard procedure it is to fight against the genes and sperms that are not active in you and you have to make them artificially active so that you can have a baby. Such babies are very sensitive as well and they can be in the future much sense that they're grown-up become very challenging and very trouble for parents as well. (Cyranoski, 2018)

  References of International Legislation on Genetically Modified Babies

Araki, M. & Ishii, T., 2014. International regulatory landscape and integration of corrective genome editing into in vitro fertilization. 85(4), pp. 871-875.

Cyranoski, D., 2018. Genome-edited baby claim provokes. pp. 1-6.

Soini, S., 2012. Genetic testing legislation in Western Europe—a fluctuating regulatory target. 3(2), p. 143–153.